Conditions: Inflammation Rheumatoid Arthritis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 63
Healthy volunteers: no

Brief summary:
This trial is conducted in Europe. The aim of this trial is to evaluate the clinical efficacy of a single dose of NNC0142-0002 administered to subjects with active rheumatoid arthritis (RA).

Detailed description:

Arms:
arm 1: Subjects received a single dose of 4 mg/kg NNC0142-0002 arm 2: Subjects received a single dose of placebo

Interventions: intervention 1: NNC0142-0002 intervention 2: placebo
Intervention descriptions: intervention 1: A single dose of 4 mg NNC 0142-0000-0002/kg bodyweight. Administered subcutaneously (s.c., under the skin). intervention 2: A single dose of 4 mg NNC 0142-0000-0002 placebo/kg bodyweight. Administered subcutaneously (s.c., under the skin).

Protocol document: